STAT4: a Critical Regulator of Inflammation in Vivo

Overview

Journal Immunol Res

Specialty Allergy & Immunology

Date 2005 May 13

PMID 15888914

Citations 96

Authors

Mark H Kaplan

Affiliations

Soon will be listed here.

Abstract

Signal transducer and activator of transcription 4 (STAT4) is a central mediator in generating inflammation during protective immune responses and immune-mediated diseases. In the 8 yr since their first description, STAT4-deficient mice have defined the role of STAT4 in a variety of in vivo model systems. Despite the extensive study and use of these mice, the exact role of STAT4 in vivo is still unclear. In this review, I focus on describing the phenotypes of STAT4-deficient immune responses to pathogens and in diseases. Comparing the effects of STAT4 deficiency among numerous model systems will further enhance the development of a systemic model of STAT4 function in vivo.

Citing Articles

Regulatory T cells and macrophages in atherosclerosis: from mechanisms to clinical significance.

Ouyang X, Liu Z Front Immunol. 2024; 15:1435021.

PMID: 39582868 PMC: 11581946. DOI: 10.3389/fimmu.2024.1435021.

Multi-dataset identification of innovative feature genes and molecular mechanisms in keratoconus.

Lyu N, Dai Y, Wu J, Fan Y, Lyu Z, Gu J J Cell Mol Med. 2024; 28(18):e70079.

PMID: 39300613 PMC: 11412914. DOI: 10.1111/jcmm.70079.

An IL-23-STAT4 pathway is required for the proinflammatory function of classical dendritic cells during CNS inflammation.

Alakhras N, Zhang W, Barros N, Sharma A, Ropa J, Priya R Proc Natl Acad Sci U S A. 2024; 121(32):e2400153121.

PMID: 39088391 PMC: 11317592. DOI: 10.1073/pnas.2400153121.

Genetic polymorphisms in genes involved in the type I interferon system (STAT4 and IRF5): association with Asian SLE patients.

Liu M, Wang S, Liang Y, Fan Y, Wang W Clin Rheumatol. 2024; 43(8):2403-2416.

PMID: 38963465 DOI: 10.1007/s10067-024-07046-8.

Transcription Factor Activity Regulating Macrophage Heterogeneity during Skin Wound Healing.

Zandigohar M, Pang J, Rodrigues A, Roberts R, Dai Y, Koh T J Immunol. 2024; 213(4):506-518.

PMID: 38940624 PMC: 11300156. DOI: 10.4049/jimmunol.2400172.

References

Sugawara I, Yamada H, Mizuno S . Relative importance of STAT4 in murine tuberculosis. J Med Microbiol. 2002; 52(Pt 1):29-34. DOI: 10.1099/jmm.0.05026-0. View

Toyoda H, Ido M, Hayashi T, Gabazza E, Suzuki K, Bu J . Impairment of IL-12-dependent STAT4 nuclear translocation in a patient with recurrent Mycobacterium avium infection. J Immunol. 2004; 172(6):3905-12. DOI: 10.4049/jimmunol.172.6.3905. View

OShea J, Gadina M, Schreiber R . Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 2002; 109 Suppl:S121-31. DOI: 10.1016/s0092-8674(02)00701-8. View

Rodriguez-Sosa M, Monteforte G, Satoskar A . Susceptibility to Leishmania mexicana infection is due to the inability to produce IL-12 rather than lack of IL-12 responsiveness. Immunol Cell Biol. 2001; 79(4):320-2. DOI: 10.1046/j.1440-1711.2001.01014.x. View

Cai G, Radzanowski T, Villegas E, Kastelein R, Hunter C . Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol. 2000; 165(5):2619-27. DOI: 10.4049/jimmunol.165.5.2619. View

Zou J, Presky D, Wu C, Gubler U . Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. J Biol Chem. 1997; 272(9):6073-7. DOI: 10.1074/jbc.272.9.6073. View

Trinchieri G . Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003; 3(2):133-46. DOI: 10.1038/nri1001. View

Land K, Moll J, Kaplan M, Seetharamaiah G . Signal transducer and activator of transcription (Stat)-6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism. Endocrinology. 2004; 145(8):3724-30. DOI: 10.1210/en.2004-0352. View

Shi H, Grusby M, Nagler-Anderson C . Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells. J Immunol. 1999; 162(9):5143-8. View

10.

Wang W, Ostlie N, Conti-Fine B, Milani M . The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Th1 cells. J Immunol. 2003; 172(1):97-103. DOI: 10.4049/jimmunol.172.1.97. View

11.

Koglin J, Gadiraju S, Russell M . Attenuated cardiac allograft vasculopathy in mice with targeted deletion of the transcription factor STAT4. Circulation. 2000; 101(9):1034-9. DOI: 10.1161/01.cir.101.9.1034. View

12.

Yamamoto K, Quelle F, Thierfelder W, Kreider B, Gilbert D, Jenkins N . Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol. 1994; 14(7):4342-9. PMC: 358805. DOI: 10.1128/mcb.14.7.4342-4349.1994. View

13.

Kaplan M, Chang H, Cooper S, Lee Y, Broxmeyer H . Distinct requirements for Stat4 and Stat6 in hematopoietic progenitor cell responses to growth factors and chemokines. J Hematother Stem Cell Res. 2003; 12(4):401-8. DOI: 10.1089/152581603322286033. View

14.

Matsukawa A, Kaplan M, Hogaboam C, Lukacs N, Kunkel S . Pivotal role of signal transducer and activator of transcription (Stat)4 and Stat6 in the innate immune response during sepsis. J Exp Med. 2001; 193(6):679-88. PMC: 2193416. DOI: 10.1084/jem.193.6.679. View

15.

Afanasyeva M, Wang Y, Kaya Z, Stafford E, Dohmen K, Sadighi Akha A . Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation. 2001; 104(25):3145-51. DOI: 10.1161/hc5001.100629. View

16.

White S, Underhill G, Kaplan M, Kansas G . Cutting edge: differential requirements for Stat4 in expression of glycosyltransferases responsible for selectin ligand formation in Th1 cells. J Immunol. 2001; 167(2):628-31. DOI: 10.4049/jimmunol.167.2.628. View

17.

Kaplan M, Whitfield J, Boros D, Grusby M . Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol. 1998; 160(4):1850-6. View

18.

Leonard W, Oshea J . Jaks and STATs: biological implications. Annu Rev Immunol. 1998; 16:293-322. DOI: 10.1146/annurev.immunol.16.1.293. View

19.

Chesler D, Reiss C . IL-12, while beneficial, is not essential for the host response to VSV encephalitis. J Neuroimmunol. 2002; 131(1-2):92-7. DOI: 10.1016/s0165-5728(02)00257-6. View

20.

Stamm L, Satoskar A, Ghosh S, David J, Satoskar A . STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis. Eur J Immunol. 1999; 29(8):2524-9. DOI: 10.1002/(SICI)1521-4141(199908)29:08<2524::AID-IMMU2524>3.0.CO;2-H. View